Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · Real-Time Price · USD
18.04
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
18.04
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Assertio Holdings Revenue
In the year 2025, Assertio Holdings had annual revenue of $118.71M, down -5.00%. Assertio Holdings had revenue of $13.54M in the quarter ending December 31, 2025, a decrease of -57.92%.
Revenue (ttm)
$118.71M
Revenue Growth
-5.00%
P/S Ratio
0.98
Revenue / Employee
$2,239,868
Employees
53
Market Cap
116.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 118.71M | -6.25M | -5.00% |
| Dec 31, 2024 | 124.96M | -27.11M | -17.83% |
| Dec 31, 2023 | 152.07M | -4.17M | -2.67% |
| Dec 31, 2022 | 156.23M | 45.22M | 40.73% |
| Dec 31, 2021 | 111.01M | 2.94M | 2.72% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurora Cannabis | 272.13M |
| Organigram Global | 204.21M |
| Lifecore Biomedical | 129.46M |
| Anika Therapeutics | 112.82M |
| Journey Medical | 61.86M |
| Cumberland Pharmaceuticals | 44.52M |
| Alpha Teknova | 40.52M |
| BGM Group | 25.10M |
ASRT News
- 6 days ago - Assertio Provides Update on Garda Therapeutics Tender Process - Business Wire
- 20 days ago - Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio - Business Wire
- 20 days ago - Assertio Announces Agreement to be Acquired by Garda Therapeutics - Business Wire
- 27 days ago - Top 2 Health Care Stocks That May Implode In April - Benzinga
- 6 weeks ago - Assertio Holdings Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Assertio Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 7 weeks ago - Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 - Business Wire
- 3 months ago - Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - Business Wire